Clinical Study of Polyherbal Formulation in the Management of Bronchial Asthma (Tamaka Swasa)
Main Article Content
Abstract
Tamaka Swasa is described as one of the five varieties of swasa mentioned in various Ayurvedic classics like Charaka Samhita, Susruta Samhita, Astanga Hrdaya, Madhava Nidana etc. In classics various single/multiple herbs and minerals has been well establish in the practice of Ayurveda. In the present study an open clinical trial has been made in 100 (one hundred) patients of bronchial asthma with an attempt to explore the efficacy of polyherbal formulation in the management of bronchial asthma. The polyherbal formulation is prepared in coarse powder and made it into kwath (decoction) form by boiling 10 gms in 200ml of water for 5-10 minutes or more till concentrated by evaporation to 50 ml. The decoctions is then keep for cooling for some time and is advice to take twice daily preferably after food continuously for three months. The result after completion of the treatment in all sign and symptoms following inclusion and exclusion criteria is seen to be so satisfactory and encouraging and further no adverse or side effect was observed in any of the patient in the entire study.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Yim M. “Healing Human Lungs Through Ayurveda”. LAP LAMBERT Academic Publishing. ISBN: 978-3-659-55313-4. Copyright © 2014. P:37-84.
II. 2.Global Initiative of Asthma. Pocket Guide for Asthma Management. ©2012. P:5. Available at www.ginastham.org.
III. World Health organization. Global surveillance, prevention and control of chronic respiratory disease: a comprehensive approach, 2007
IV. Masoli M, Fabian D, Hoplt S, Beasly R. The global Burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59(4):469-78.
V. Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lal E. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997; 99:314-22.
VI. Peat JK, Haby M, Spijker J, Berry G, Woolcock AJ, Prevalence of asthma in adults in Busselton, Western Australia. BMJ 1992;305: 1326-9.
VII. Dubosi P, Degrave E, Vandenplas O. Asthma and airway hyper-responsiveness among Belgian conscripts, 1978-91. Thorax 1998; 53: 101-5.
VIII. Peat JK, GrayEJ, Mellis CM, Leeder SR, Woolcock AJ. Differences in airway responsiveness between children and adult living in the same environment: an epidemiological study in two regions of New South Wales. Eur Respir J 1994; 7: 1805-13
IX. Veale AJ, Peat JK, Tovey ER, Salome CM, Thompson JE, Woolcock AJ. Asthma and atopy in four rural Asustralian aboriginal communities, Med J Aust 1996; 165: 192-6.
X. Chinn S, Burney P, Jarvis D, Luczynska C, Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1997; 10:2495-2501.
XI. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self reported asthma attack, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9:687-95.
XII. Devereux G, Ayatollahi T, Ward R, Bromly C, Bourke SJ, Stenton SC, et al. Asthma, airways responsiveness and air pollution in two contrasting districts of north England. Thorax 1996; 51: 169-74.
XIII. Zamel N, McClean PA, Sandell PR, Siminovitch KA, Slutsky AS. Asthma on Tristan da Cunha: Looking for the genetic link. The University of Toronto Genetics of Asthma Research Group. Am J Respir Crit Care Med 1996; 153:1902-6.
XIV. Viswanathan R, Prasad M, Thakur AK, Sinha SP, Prakash N, Mody RK, et al. Epidemiology of asthma in an urban population: a random morbidity survey. J Indian Med Assoc 1966; 46:480-3.
XV. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive study approach, 2007.
XVI. Amrendra K, Balaram Ghosh, “Genetics of asthma: a molecular biologist perspective”, Clinical and Molecular Allergy 2009, p 1-9.
XVII. D. Behera. Bronchial Asthma ©2000, First Edition: 2000, Published by Jitendar P. Vij, ISBN 81-7179-722-9.
XVIII. Kawakami Y. Genetic background of bronchial asthma. [Internet]. Available at
a. http://www.ncbi.nlm.nih.gov/pubmed/130621.
XIX. Heinzmann A, Dietrich H, Deichmann KA. “Association of uteroglobulin-related protein 1 with bronchial asthma” [Internet]. Available at http://ww.ncbi.nlm.nih.gov/pubmed/ 12915772.
XX. Gupta P, Vijayan VK, Bansal SK. “Changes in protein profile of erythrocyte membrane in bronchial asthma”. J Asthma. 2012 Mar;49(2).p129-133.
XXI. Bierbaum S, Heinzmann A. “The genetic of bronchial asthma in children”. Respir Med. 2007 Jul;101(7),p1369-1375.
XXII. GraphPad by Dotmatics ”t-test calculator”. [Internet]. Cited on February 1-28, 2023. Available at.
a. https://www.graphpad.com/quickcalcs/ttest1.cfm.
XXIII. Sarma, Pegu. “ Herbs in the management of bronchial asthma and Adhatoda Vasica in Silico”. LAP LAMBERT Academic Publishing. Copyright © 2019. ISBN: 978-613-9-99412-0.
XXIV. Yim M et al: Exploring the Possible Mechanism of Albizzia lebbeck Compound Binding with Drug Targets of Bronchial Asthma – an insilico and clinical analysis. Int J Pharma Sci Res 2014, 5(11). 5042-51.doi: 10.13040/IJPSR.0975-8232.5(11).5042-51.
XXV. Rigom Pegu et al.2017, Clincal Anlysis of Poly Herbal Compounds In The Management of Tamaka Śwāsa (Bronchial Asthma) – An In Silico Approach of Vasaka (Adhatoda vasica Nees)”. Int J Recent Sci Res. 8(12), pp. 22146-22152. DOI: http://dx.doi.org/10.24327/ijrsr.2017.0812.1209